|
Edinburgh Research Archive >
Biological Sciences, School of >
Biological Sciences publications >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/1842/741
|
| Title: | Malaria transmission-blocking vaccines—how can their development be supported? |
| Authors: | Carter, Richard
Mendis, Kamini N
Miller, Louis H
Molineaux, Louis
Saul, Allan |
| Issue Date: | Mar-2000 |
| Citation: | Carter R, Mendis KN, Miller LH, Molineaux L, Saul A, NATURE MEDICINE, 6 (3): 241-244 MAR 2000 |
| Publisher: | Nature Publishing Group |
| Abstract: | Malaria is a disease of poor countries. The development of malaria vaccines requires considerable investment, for
which there is little commercial interest, particularly for transmission-blocking vaccines that have the
public health objective of protecting communities from the spread of malaria rather than protecting
individuals from the disease. Here, Carter et al. summarize the report of a committee of experts on the
relevance and prospects for these vaccines. |
| Keywords: | Malaria
transmission-blocking
vaccines |
| URI: | http://medicine.nature.com
http://hdl.handle.net/1842/741 |
| Appears in Collections: | Biological Sciences publications
|
Items in ERA are protected by copyright, with all rights reserved, unless otherwise indicated.
|
